QSAR study of 1,3-dioxo-4-methyl-2,3-dihydro-1h-pyrrolo[3,4-c]quinolines as caspase-3 inhibitors

Medicinal Chemistry Research

Volumn 17, Issue 2-7, 2008, Pages 399-411

  Sharma, Simant ^a   Sahu, Kamlesh ^a   Jain, Prateek ^a   Mourya, V K ^a   Agrawal, Ram K ^a  

^a DR H S GOUR UNIVERSITY   (India)

Author keywords

CASPASE inhibitor; QSAR; Quinolines

Indexed keywords

CASPASE 3 INHIBITOR; QUINOLINE DERIVATIVE;

BIOLOGICAL ACTIVITY; CONFERENCE PAPER; DRUG POTENCY; PARTITION COEFFICIENT; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

EID: 52949129170     PISSN: 10542523     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00044-007-9075-y     Document Type: Conference Paper

References (15)

1. DM Anselmo FF Amersi XD Shen F Gao M Katori C Lassman B Ke AJ Coito J Ma V Brinkmann RW Busuttil JW Kupiec-Weglinski DG Farmer 2002 FTY720 pretreatment reduces warm hepatic ischemia reperfusion injury through inhibition of T-lymphocyte infiltration. Am J Transplant 2 843 849
2. JG Chapman WP Magee HA Stukenbrok GE Beckius AJ Milici WR Tracey 2002 A novel nonpeptide caspase-3/7 inhibitor, (S)-(+)-5-[1-(2- methoxymethylpyrrolidinyl)sulfonyl]isatin reduces myocardial ischemic injury. Eur J Pharmacol 456 59 68
3. BH Han D Xu J Choi Y Han S Xanthoudakis S Roy J Tam J Vaillancourt J Colucci R Siman A Giroux GS Robertson R Zamboni DW Nicholson DM Holtzman 2002 Selective, reversible caspase-3 inhibitor is neuroprotective and reveals distinct pathways of cell death after neonatal hypoxic-ischemic brain injury. J Biol Chem 277 30128 30136
4. A Haunstetter S Izumo 1998 Apoptosis: basic mechanisms and implications for cardiovascular disease. Circ Res 82 1111 1129
5. NC Hoglen LS Chen CD Fisher BP Hirakawa T Groessl PC Contreras 2004 Characterization of IDN-6556 (3-[2-(2-tert-butyl-phenylaminooxalyl)-amino]- propionylamino]-4-oxo-5-(2,3,5,6-tetrafluoro- phenoxy)- pentanoic acid): a liver-targeted caspase inhibitor. J Pharmacol Exp Ther 309 634 640
6. MD Jacobson 1998 Anti-apoptosis therapy: a way of treating neural degeneration. Curr Biol 8 418 421
7. DV Kravchenko VV Kysil AP Ilyn SE Tkachenko S Maliarchouk IM Okun AV Ivachtchenko 2005 1,3-Dioxo-4-methyl-2,3-dihydro-1H-pyrrolo[3,4-c]quinolines as potent caspase-3 inhibitors. Bioorg Med Chem Lett 15 1841 1845
8. CA Marques U Keil A Bonert B Steiner C Haass WE Muller A Eckert 2003 Neurotoxic mechanisms caused by the Alzheimer's disease-linked Swedish amyloid precursor protein mutation: oxidative stress, caspases, and the JNK pathway. J Biol Chem 278 28294 28302
9. A Mohr RM Zwacka 2007 In situ trapping of initiator caspases reveals intermediate surprises. Cell Biol Int 31 526 530
10. AL Parrill 2003 HIV-1 integrase inhibition: binding sites, structure acti vityrelationships and future perspectives. Curr Med Chem 10 1811 1824
11. CW Scott C Sobotka-Briner DE Wilkins RT Jacobs JJ Folmer WJ Frazee RV Bhat SV Ghanekar D Aharony 2003 Novel small molecule inhibitors of caspase-3 block cellular and biochemical features of apoptosis. J Pharmacol Exp Ther 304 433 440
12. QM Wang RB Johnson LN Jungheim JD Cohen EC Villarreal 1998 Dualinhibition of human rhinovirus 2A and 3C proteases by homophthalimides. Antimicrob Agents Chemother 42 916 920
13. SE Webber K Okano TL Little SH Reich Y Xin SA Fuhrman DA Matthews RA Love TF Hendrickson AK Patick JW Meador RA Ferre EL Brown CE Ford SL Binford ST Worland 1998 Tripeptide aldehyde inhibitors of human rhinovirus 3C protease: design, synthesis, biological evaluation, and cocrystal structure solution of P1 glutamine isosteric replacements. J Med Chem 41 2786 2805
14. SE Webber J Tikhe ST Worland SA Fuhrman TF Hendrickson DA Matthews RA Love AK Patick JW Meador RA Ferre EL Brown DA DeLisle CE Ford SL Binford 1996 Design, synthesis, and evaluation of nonpeptidic inhibitors of human rhinovirus 3C protease. J Med Chem 39 5072 5082
15. C Wellington M Hayden 2000 Caspases and neurodegeneration: on the cutting edge of new therapeutic approaches. Clin Genet 57 1 10